How many insider trades does FilingIQ track for PLUR?

FilingIQ tracks 42 Form 4 insider transactions for PLUR (Pluri Inc.), covering filings from Dec 20, 2022 onwards. 4 of those were filed in the last 90 days.

Are PLUR insiders net buyers or net sellers?

Across the full Form 4 history for PLUR, 3 transactions (7%) were open-market purchases and 1 (2%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does PLUR insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is PLUR in?

Pluri Inc. (PLUR) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $32.36M.

PLUR insider trading

NasdaqCM Healthcare

Pluri Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

7% / 2%

Market cap

$32.36M

About Pluri Inc.

Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries. It develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions; and immunotherapy platform. The company's product candidates include PLX-PAD, that is composed of maternal mesenchymal stromal cells originating from the placenta for the treatment of various indications, such as acute muscle injuries following hip fracture, acute respiratory distress syndrome due to coronavirus Disease (COVID-19), peripheral artery disease, intermittent claudication, and critical limb ischemia; PLX-R18, composed of fetal MSC like cells originating from the placenta for the treatment of hematopoietic complications of the H-ARS, and is in Phase I clinical trial to treat hematopoietic cell transplantation; and allogeneic MAIT cell therapy platform. It also offers cell manufacturing services and cell-based coffee; and develops and commercializes cultivated meat products. The company operates in the field of regenerative medicine, food tech, immunotherapy, CDMO, and AgTech. It has collaboration agreement with Bar-Ilan University to advance cancer immunotherapy for solid tumors. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel.

Company website: www.pluri-biotech.com

PLUR insider activity at a glance

FilingIQ has scored 42 insider transactions for PLUR since Dec 20, 2022. The most recent filing in our index is dated Apr 21, 2026.

Across the full history, 3 open-market purchases and 1 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on PLUR insider trades is 61.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live PLUR trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for PLUR?: FilingIQ tracks 42 Form 4 insider transactions for PLUR (Pluri Inc.), covering filings from Dec 20, 2022 onwards. 4 of those were filed in the last 90 days.
Are PLUR insiders net buyers or net sellers?: Across the full Form 4 history for PLUR, 3 transactions (7%) were open-market purchases and 1 (2%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does PLUR insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is PLUR in?: Pluri Inc. (PLUR) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $32.36M.

Methodology & sources

Every PLUR insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.